デフォルト表紙
市場調査レポート
商品コード
1678452

標的治療の世界市場レポート 2025

Targeted Therapy Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
標的治療の世界市場レポート 2025
出版日: 2025年03月03日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

標的治療市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率(CAGR)は8.0%で、1,514億8,000万米ドルに成長します。予測期間の成長は、腫瘍学研究の拡大、精密医療への需要の高まり、免疫療法の出現、バイオ医薬品への投資の増加、患者の意識と支持に起因すると考えられます。予測期間における主な動向としては、創薬における人工知能(AI)の統合、治療決定における患者のアドボカシーと関与、コンパニオン診断薬の拡大、迅速な承認に対する規制当局の支援、バイオテクノロジーと製薬への投資の増加などが挙げられます。

がん罹患率の上昇は、今後数年間の標的治療市場の成長を促進すると予想されます。がんとは、周囲の組織に侵入して制御不能に増殖する異常細胞を特徴とする疾患群を指します。標的治療は、がん細胞の増殖を促進するシグナルを遮断したり、がん細胞の自己破壊を促したりすることで効果を発揮します。がん細胞の増殖と生存を促進する遺伝子やタンパク質を特異的に標的とするように設計された薬剤を利用することで、その需要を高めています。例えば、2024年1月、米国に本部を置く非営利団体である米国がん協会は、がん患者数が2023年の1,958,310人から2,001,140人に増加し、2.19%の伸びを示したと報告しました。このように、がんの有病率の増加は、標的治療市場の成長を刺激すると予想されます。

予想される成長は、政府の取り組みや資金提供の増加によって後押しされる見込みです。政府の取り組みや資金提供には、ヘルスケア、科学、技術、教育などさまざまな部門にわたって政府機関が提供する行動や財政的支援が含まれます。このような支援は、標的治療の推進において重要な役割を果たしており、精密医療の研究開発に重点を置くことで、適応治療の商業的拡大に貢献しています。2023年11月、米国の科学技術統計センター(National Center for Science and Engineering Statistics)は、2021年の研究開発費25億1,300万米ドルに対し、5.2%増の26億4,400万米ドルに達すると報告しました。このような財政的裏付けは、標的治療市場の成長を牽引する政府支援の役割を強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界標的治療PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の標的治療市場:成長率分析
  • 世界の標的治療市場の実績:規模と成長, 2019-2024
  • 世界の標的治療市場の予測:規模と成長, 2024-2029, 2034F
  • 世界標的治療総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の標的治療市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 低分子医薬品
  • モノクローナル抗体
  • 世界の標的治療市場:流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 世界の標的治療市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 乳がん
  • 大腸がん
  • 白血病
  • 肺がん
  • リンパ腫
  • 腎臓がん
  • その他の用途
  • 世界の標的治療市場、低分子医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • チロシンキナーゼ阻害剤(TKI)
  • プロテアソーム阻害剤
  • ホスファチジルイノシトール3-キナーゼ(PI3K)阻害剤
  • その他の小分子療法
  • 世界の標的治療市場、モノクローナル抗体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 免疫チェックポイント阻害剤
  • 抗体薬物複合体(ADC)
  • サイトカイン阻害剤
  • その他のモノクローナル抗体

第7章 地域別・国別分析

  • 世界の標的治療市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の標的治療市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 標的治療市場:競合情勢
  • 標的治療市場:企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Bristol Myers Squibb
  • AstraZeneca
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Genmab A/S
  • Regeneron Pharmaceuticals Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals Incorporated
  • Agilent Technologies Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 標的治療市場2029:新たな機会を提供する国
  • 標的治療市場2029:新たな機会を提供するセグメント
  • 標的治療市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r27095

Targeted therapy is a type of cancer treatment that utilizes medications or chemicals to specifically attack molecules crucial for the survival and spread of cancer cells. This approach involves drugs targeting specific genes and proteins that support the survival and growth of cancer cells.

Targeted therapy involves small molecule medicines and monoclonal antibodies. Small-molecule medicines are synthetic chemicals inspired by or derived from natural products, distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies. They are used for treating various cancers, including breast cancer, colorectal cancer, leukemia, lung cancer, lymphoma, and renal cancer.

The targeted therapy market research report is one of a series of new reports from The Business Research Company that provides targeted therapy market statistics, including targeted therapy industry global market size, regional shares, competitors with a targeted therapy market share, detailed targeted therapy market segments, market trends and opportunities, and any further data you may need to thrive in the targeted therapy industry. This targeted therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The targeted therapy market size has grown strongly in recent years. It will grow from $103.84 billion in 2024 to $111.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to advancements in molecular biology, increasing cancer incidence, personalized medicine trend, FDA approvals and regulatory support.

The targeted therapy market size is expected to see strong growth in the next few years. It will grow to $151.48 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to expanding oncology research, rising demand for precision medicine, emergence of immunotherapies, growing investment in biopharmaceuticals, patient awareness and advocacy. Major trends in the forecast period include integration of artificial intelligence (AI) in drug discovery, patient advocacy and involvement in treatment decisions, expansion of companion diagnostics, regulatory support for expedited approvals, increasing investment in biotechnology and pharma.

The rising incidence of cancer is anticipated to drive the growth of the targeted therapy market in the coming years. Cancer refers to a group of conditions characterized by abnormal cells that can invade surrounding tissues and proliferate uncontrollably. Targeted therapy works by interrupting the signals that promote the growth of cancer cells or by prompting these cells to self-destruct. It utilizes medications designed to specifically target the genes and proteins that facilitate the growth and survival of cancer cells, thereby increasing its demand. For example, in January 2024, the American Cancer Society, a nonprofit organization based in the U.S., reported that the number of cancer cases rose to 2,001,140, up from 1,958,310 in 2023, marking a growth of 2.19%. Thus, the increasing prevalence of cancer is expected to stimulate the growth of the targeted therapy market.

The anticipated growth is expected to be bolstered by increasing government initiatives and funding. Government initiatives and funding encompass actions and financial support provided by government agencies across various sectors, including healthcare, science, technology, and education. Such support plays a crucial role in advancing targeted therapies, with a focus on research and development in precision medicine contributing to the commercial expansion of adapted therapies. In November 2023, the National Center for Science and Engineering Statistics, a US-based agency, reported a 5.2% increase in expenditures on research and experimental development, reaching $2.644 billion compared to the 2021 expenditures of $2.513 billion. This financial backing underscores the role of government support in driving the growth of the targeted therapy market.

Major companies in the targeted therapy market are actively engaged in developing innovative technological solutions to enhance their market position. For instance, in March 2022, Novartis AG, a Swiss multinational pharmaceutical corporation, introduced Pluvicto, the first FDA-approved targeted radioligand therapy (RLT) for eligible patients with metastatic castration-resistant prostate cancer (mCRPC). Pluvicto combines a therapeutic radioisotope with a targeted chemical, representing a significant advancement in targeted cancer therapy. By binding to specific cells, including prostate cancer cells expressing the transmembrane protein PSMA, Pluvicto's radioisotope induces energy emissions that damage target cells and adjacent ones, impeding replication and potentially leading to cell death.

Companies in the targeted therapy market are also prioritizing strategic partnerships to enhance service offerings. One such example is Shine Technologies, a US-based pharmaceutical company specializing in radioactive isotopes, which partnered with Curadh MTR Inc. in September 2023. Curadh MTR Inc. focuses on advancing molecularly targeted radiation therapies for solid tumors. This collaboration aims to leverage radioisotopes' potential to precisely target and eliminate cancer cells, providing new prospects for patients and reshaping the landscape of cancer treatment.

In August 2022, Bristol Myers Squibb, a US-based biopharmaceutical company, made a strategic move by acquiring Turning Point Therapeutics for an undisclosed amount. This acquisition positions Bristol Myers Squibb to address a critical medical need for patients with non-small cell lung cancer testing positive for ROS1. Additionally, it grants access to a pipeline of experimental drugs, including repotrectinib, targeting prevalent mutations associated with oncogenesis. Turning Point Therapeutics, Inc., the acquired company, operates in the targeted therapy sector as a clinical-stage precision oncology company.

Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the targeted therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The targeted therapy market includes revenues earned by entities by providing various kinds of cancer drugs, such as EGFR inhibitors, angiogenesis inhibitors, and apoptosis inducers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Targeted Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on targeted therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for targeted therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The targeted therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Small Molecule Medicines; Monoclonal Antibodies
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 3) By Application: Breast Cancer; Colorectal Cancer; Leukemia; Lung Cancer; Lymphoma; Renal Cancer; Other Applications
  • Subsegments:
  • 1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs); Proteasome Inhibitors; Phosphatidylinositol 3-Kinase (PI3K) Inhibitors; Other Small Molecule Therapies
  • 2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors; Antibody-Drug Conjugates (ADCs); Cytokine Blockers; Other Monoclonal Antibodies
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Merck & Co Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Targeted Therapy Market Characteristics

3. Targeted Therapy Market Trends And Strategies

4. Targeted Therapy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Targeted Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Targeted Therapy Market Growth Rate Analysis
  • 5.4. Global Targeted Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Targeted Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Targeted Therapy Total Addressable Market (TAM)

6. Targeted Therapy Market Segmentation

  • 6.1. Global Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Molecule Medicines
  • Monoclonal Antibodies
  • 6.2. Global Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.3. Global Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Renal Cancer
  • Other Applications
  • 6.4. Global Targeted Therapy Market, Sub-Segmentation Of Small Molecule Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tyrosine Kinase Inhibitors (TKIs)
  • Proteasome Inhibitors
  • Phosphatidylinositol 3-Kinase (PI3K) Inhibitors
  • Other Small Molecule Therapies
  • 6.5. Global Targeted Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immune Checkpoint Inhibitors
  • Antibody-Drug Conjugates (ADCs)
  • Cytokine Blockers
  • Other Monoclonal Antibodies

7. Targeted Therapy Market Regional And Country Analysis

  • 7.1. Global Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Targeted Therapy Market

  • 8.1. Asia-Pacific Targeted Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Targeted Therapy Market

  • 9.1. China Targeted Therapy Market Overview
  • 9.2. China Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Targeted Therapy Market

  • 10.1. India Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Targeted Therapy Market

  • 11.1. Japan Targeted Therapy Market Overview
  • 11.2. Japan Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Targeted Therapy Market

  • 12.1. Australia Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Targeted Therapy Market

  • 13.1. Indonesia Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Targeted Therapy Market

  • 14.1. South Korea Targeted Therapy Market Overview
  • 14.2. South Korea Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Targeted Therapy Market

  • 15.1. Western Europe Targeted Therapy Market Overview
  • 15.2. Western Europe Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Targeted Therapy Market

  • 16.1. UK Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Targeted Therapy Market

  • 17.1. Germany Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Targeted Therapy Market

  • 18.1. France Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Targeted Therapy Market

  • 19.1. Italy Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Targeted Therapy Market

  • 20.1. Spain Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Targeted Therapy Market

  • 21.1. Eastern Europe Targeted Therapy Market Overview
  • 21.2. Eastern Europe Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Targeted Therapy Market

  • 22.1. Russia Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Targeted Therapy Market

  • 23.1. North America Targeted Therapy Market Overview
  • 23.2. North America Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Targeted Therapy Market

  • 24.1. USA Targeted Therapy Market Overview
  • 24.2. USA Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Targeted Therapy Market

  • 25.1. Canada Targeted Therapy Market Overview
  • 25.2. Canada Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Targeted Therapy Market

  • 26.1. South America Targeted Therapy Market Overview
  • 26.2. South America Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Targeted Therapy Market

  • 27.1. Brazil Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Targeted Therapy Market

  • 28.1. Middle East Targeted Therapy Market Overview
  • 28.2. Middle East Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Targeted Therapy Market

  • 29.1. Africa Targeted Therapy Market Overview
  • 29.2. Africa Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Targeted Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Targeted Therapy Market Competitive Landscape
  • 30.2. Targeted Therapy Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Targeted Therapy Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Novartis AG
  • 31.3. Sanofi SA
  • 31.4. Bristol Myers Squibb
  • 31.5. AstraZeneca
  • 31.6. GlaxoSmithKline plc
  • 31.7. Takeda Pharmaceutical Company Limited
  • 31.8. Eli Lilly and Company
  • 31.9. Gilead Sciences Inc.
  • 31.10. Amgen Inc.
  • 31.11. Genmab A/S
  • 31.12. Regeneron Pharmaceuticals Inc.
  • 31.13. Biogen Inc.
  • 31.14. Vertex Pharmaceuticals Incorporated
  • 31.15. Agilent Technologies Inc.

32. Global Targeted Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Targeted Therapy Market

34. Recent Developments In The Targeted Therapy Market

35. Targeted Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Targeted Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Targeted Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Targeted Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer